In the modern epidemiological landscape, the demand for Infectious Disease Testing Solutions has transitioned from periodic clinical needs to a cornerstone of national security and public health infrastructure. As a premier supplier and exporter, Shenzhen BioX Medical Co., Ltd. stands at the forefront of this evolution, bridging the gap between sophisticated laboratory science and practical, scalable field applications.
Our commitment to E-E-A-T principles (Experience, Expertise, Authoritativeness, and Trustworthiness) ensures that every PCR analyzer and nucleic acid extraction system we export meets the rigorous demands of global diagnostic standards.
Established Year
Sqm Facility
Expert Employees
Exporting Countries
Being based in Shenzhen allows BioX Medical to leverage the world's most advanced electronics and biotechnology supply chain. This means faster prototyping, rigorous component testing, and unmatched cost-efficiency for molecular diagnostic systems.
Our proximity to top-tier engineering talent and research institutions enables us to integrate the latest advancements in real-time fluorescent quantitative PCR and automated liquid handling faster than Western counterparts.
With over 9,000 square meters of production space, we offer high-volume throughput for global emergency response, ensuring that large-scale testing mandates are met without supply chain bottlenecks.
Navigating the complex world of international medical device regulations requires more than just a high-quality product; it requires Regulatory Authoritativeness. Shenzhen BioX Medical Co., Ltd. provides extensive support for:
Our solutions are designed with Local Application Scenarios in mind—from ultra-precise laboratory settings in Germany to mobile testing clinics in remote regions of Africa, where power stability and ease of maintenance are critical.
Integrating machine learning algorithms to interpret complex PCR curves, reducing human error and increasing diagnostic sensitivity for multi-pathogen detection.
The shift towards Point-of-Care Testing (POCT) requires smaller, more robust systems like our BK-Autohs96, which maintain lab-grade accuracy in decentralized environments.
Simultaneous detection of multiple viruses (e.g., Flu A, Flu B, and COVID-19) in a single run, optimizing laboratory throughput and patient outcomes.
Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
For standard molecular diagnostic systems, our lead time typically ranges from 2 to 4 weeks, depending on the order volume and customization requirements. Our Shenzhen facility maintains a buffer stock of key components to ensure rapid deployment during health emergencies.
Yes, we provide comprehensive technical support including remote installation guidance, video training modules, and, for large-scale institutional deployments, on-site training conducted by our multidisciplinary team of engineers.
Our systems are designed as open platforms, meaning they are compatible with most high-quality, commercially available nucleic acid extraction and PCR reagent kits, providing laboratories with maximum operational flexibility.
We use medical-grade, reinforced packaging with optional temperature-monitoring sensors for sensitive components. All exports undergo a final 72-hour stress test before being cleared for shipment.
BioX Medical
